ri:val is the leading valuation solution for business developers, investors, CFOs, and CEOs in pharma and biotech. You can generate valuation results far beyond any error-prone spreadsheet calculation and quickly explore multiple scenarios. ri:val provides access to up-to-date industry data on drug development. Valuations of license contracts, drug development projects, pipelines, and biotech or pharma firms are easily done in a comprehensive, user-friendly framework.
Valuation is no longer a challenge—it is your tool for success.